{"name":"Levo Therapeutics, Inc.","slug":"levo-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1SdDZGVHVjZ2V0OEhvUS1MMGdwZnhkYk1maDFlZlEwV2VYZEU3OWlBQUh1VGVlWnRXT2JXandYbURxempCWnQwSXhpaFBEdWpZcVhoVmhuanowbDlNdTlCX3dOUTRzOHRQckE?oc=5","date":"2025-10-01","type":"regulatory","source":"Psychiatry Online","summary":"Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis - Psychiatry Online","headline":"Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQYlM2aTZxYkd0X19ZaE04VndfYXBpRXhBOXhLMzBleGdaYTRGLUltekgyOFNsMlcwQ0pMLWJUeDlfRVo0NHFCTnIzVjI4cnBTZUNvdDY2MHNwNVpPMnNNdHRaWnc4eGxuWl9SYlhRUmlDZko3OXpabkloTFFiQkRPMkJIdm9aanNqSU5FaEJobXFyTGtsYWpiNw?oc=5","date":"2025-09-25","type":"trial","source":"Prader-Willi Syndrome News","summary":"PWS-related hyperphagia drug ACP-101 fails to meet trial goals - Prader-Willi Syndrome News","headline":"PWS-related hyperphagia drug ACP-101 fails to meet trial goals - Prader","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQWG9pN09iSFlRb2JsSlV6VVMySGNZR2VsSmVXS1JNbVVScDdLX3M1WWNtRTdKa0xLLWZiRy1hNUc2elVNcTJFemdweTVadEoxM1A3WDJHT0s4ZklMYWVyalZuSjNKNW1JeGFIWmlFTG9aWFZINGItVW9jMHhfQllmTGN0YldBWk45SDNxRmVTTU1xWlg5M1BXV3BrdlRodzQwUHNQX3V0VQ?oc=5","date":"2025-09-24","type":"trial","source":"BioPharma Dive","summary":"Acadia to scrap Prader-Willi drug after study setback - BioPharma Dive","headline":"Acadia to scrap Prader-Willi drug after study setback","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPX0tJOGt1eWNmcTc3dEdmY0ZwaGpNNHhzRVBIazhjV3YzWDJjNzNJZy1NYXFSWVItQVlVQ0tfdUN1TkZoMXB3cG9hUm5CWTFfRUZkbS1xVDNEbW5YYXpuNmdaSEhCVG54NkY3aDNzVHQ4elhZakFaaVpfRFpQeFQ4ZjVuVkJZY2dEX1FFY3hrcmRXWk94VlRLaUk4X0g5QVVfQXNTamtON1dpV2NIMTZZVURlS0U?oc=5","date":"2025-09-24","type":"trial","source":"Fierce Pharma","summary":"Acadia grounds Prader-Willi candidate after trial failure, leaving the market to Soleno - Fierce Pharma","headline":"Acadia grounds Prader-Willi candidate after trial failure, leaving the market to Soleno","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPOUR4Vlp1cFFCbnhPdTJKUF9zaGhjRnk3eUF5d19JQXRqeGFGV25aR1RodDVSOU1sUDZqSHdmV2FlaTVVd1FVNVNYa3BLS0hSSl9NUUpkelNkUl9GUi1sR2N5bkZPTjhtdDltNEYwLUs1WkV3aW85TjVMYUVGcVh2aWlfVnV4MFlXYk9XNlZQTnZ5WkR2WDdMUGRfdDNtbV9KTlNEeHVqZEFtdk1Mc2c?oc=5","date":"2025-09-24","type":"pipeline","source":"Seeking Alpha","summary":"Acadia Pharmaceuticals: Reeling After PWS Failure - Downgrading To Hold (NASDAQ:ACAD) - Seeking Alpha","headline":"Acadia Pharmaceuticals: Reeling After PWS Failure - Downgrading To Hold (NASDAQ:ACAD)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNOWkwNF8zTEppQTlYa3VnOWI0b2ROVnEyNWxRVnBiM25ZejNJWDNRLU9SLXlLbDI5OTRqSmFENzdrLTN2cG8wQjRXaXRvcGlnbU5Xa1BLUlRIWGpVWU1YTGEwYkRoRzRTOVFPVHdmNS14TkV1dVl6V1FsRkdkMmxQeW1JT2hpcHE1c19QMTRidzNkakdSODh0TGxJc3hwZGFmUVFmV2Nfb2FXNVU?oc=5","date":"2025-07-15","type":"pipeline","source":"BioSpace","summary":"Acadia Debuts New Team, Pipeline With ‘Biotech Powerhouse’ Ambitions - BioSpace","headline":"Acadia Debuts New Team, Pipeline With ‘Biotech Powerhouse’ Ambitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPOWQzRUZ0YXB3aUdaN3FCNlBKQmhyMFJmM09SQUN1RTdnd1JGMGNoWHA2T0FvMHJrX2JhbE4ta0VwbXItWXFtN013QVVNZU9fa09UMG5HSkwzUUxNUE5ESkVCUVVLUWlIUHI3R1BOTUdwdUoyclM0c3pkOGVfWnhtbV91UVFFYzVMRktvdTlzMlhrdXFPeXc?oc=5","date":"2025-05-15","type":"trial","source":"Prader-Willi Syndrome News","summary":"Top-line Phase 3 trial data on ACP-101 for PWS expected this year - Prader-Willi Syndrome News","headline":"Top-line Phase 3 trial data on ACP-101 for PWS expected this year - Prader","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPSWpWU3kzVmVaTzBuNUNrR21RUVRSWmgwaXlYdWlqZUJjOUczVUNuYWhxSU42aXhIZ1dhZEg5Z3Ewam9IUUN4dmxDTDc1Y1lBZGFWVjJxeWg0UklkMEs3WlpkRWJwUU5XQXNMd0c2bmtvclpNU0ktS1lMVTRQQVk0bHo3TUVIUHBjb0JTMktwMFBtME0tODlhTzk0MjBJOWNPZ3Y0WjJzN2JBS1JBZkhxQ2JvMEd6eHc?oc=5","date":"2025-03-27","type":"regulatory","source":"MedCity News","summary":"Rare Metabolic Disease That Leads to Childhood Obesity Gets Its First FDA-Approved Drug - MedCity News","headline":"Rare Metabolic Disease That Leads to Childhood Obesity Gets Its First FDA-Approved Drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQQVJhT2tEV1B3MGJqcmZEM2ZMeDlNWGlIRWRtay1pOUdQSWdISFNERF9DczZaa3hVeFMxdmFqa3dIcUVEYjZSYU5fRURFSHp2cUdaQy11eHJWNm0zbjhjNThkb3hFam5KX19pRFAycVF5ZUw2MmN5d0hXbHdNSnJkTHFNUU1sQUhabFRXREotUTdtWFNrM3NfMzZ2MzVLWmJNSFdYQVBpRHVUYWhMbXNPekd6dEFmdFdwMl9tbTlHOUp6WWlaT0ZmLVpScUczS3JzVG5YRmh2UE1NN1VNVWNZSVF2bGQ5WUhHWTlZcE9feEY2X0ZwS0E?oc=5","date":"2025-02-13","type":"pipeline","source":"BioSpace","summary":"Prader-Willi Syndrome Market Size to Reach USD 1,302.9 Million by 2035, Impelled by Increasing Awareness and Diagnosis Rates - BioSpace","headline":"Prader-Willi Syndrome Market Size to Reach USD 1,302.9 Million by 2035, Impelled by Increasing Awareness and Diagnosis R","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOb240dzlod3dGU3RJMWxRaHJxbHRyMWp0S3FQUUUzci16ZHZUZENnVVUyb001cHhubURfQWo2LVhWdnIwTVVqdFVLY3ZNMXdnRGxOSkRuUXM3LVRDbGVxd0JUcFY4VHBUQjZrZXBkWEVmcGppNzdfUWg5X0lKTFFQeFFYT0p2cHptOXF3?oc=5","date":"2024-04-12","type":"trial","source":"Pharma Voice","summary":"3 big recent trial flops - Pharma Voice","headline":"3 big recent trial flops","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-11-13","type":"pipeline","source":"PR Newswire","summary":"Prader-Willi Syndrome Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Leading Companies - Neuren, Aardvark, Jazz, Gedeon Richter, Harmony Biosciences, Soleno The","headline":"Prader-Willi Syndrome Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Leading Com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPZWxPLW81UkJTb1gxVmdMMUlfcGhoZHNJejhTMDNtVExFWmJwZGFUWXJPbDQtWklnSU5zczVoa1V1d25EeUczMk0tN3pSSzBndHNtQ1FOU0d6WEJqaWUxMFRmMmZmcDdweFZ6aGc1QWlnV2ZjZnlBZFZuZ09GQkkxZy1iZUs?oc=5","date":"2023-06-14","type":"pipeline","source":"BioPharma Dive","summary":"Acadia gives once-rejected Prader-Willi drug a second chance - BioPharma Dive","headline":"Acadia gives once-rejected Prader-Willi drug a second chance","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}